Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine in adolescent bipolar depression
NCT00232414Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Oct 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in bipolar I disorder, sponsored by University of Cincinnati. Primary endpoint: Children's Depression Rating Scale at 8 weeks. Started Oct 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00232414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232414.